Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 3Active not recruiting 2Completed 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Gynecologic 5Sarcoma 3CNS 3Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Gastrointestinal 2Plasma cell 1Breast 1

Conditions

Prostatic Neoplasms 4Stage I Prostate Adenocarcinoma AJCC v7 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 161Specimen Handling 134enzalutamide 125Nivolumab 118Gemcitabine 96Docetaxel 92Radiosurgery 91Prednisone 81Androgen Antagonists 81Abiraterone Acetate 79Radiotherapy 75apalutamide 66Cisplatin 65darolutamide 62Ipilimumab 61Biopsy 61abiraterone 57cabozantinib 55Carboplatin 55Leuprolide 52enfortumab vedotin 50Radiation 47Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 38acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Congresses as Topic × Genitourinary × 1 year × Clear all
NCT04423211 2026-05-15

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Eastern Cooperative Oncology Group

Phase 3 Recruiting
804 enrolled
Genitourinary

Prostatic Neoplasms

NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

NCT05946213 2026-05-07

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

NRG Oncology

Phase 3 Recruiting
1,209 enrolled
Genitourinary

Prostatic Neoplasms

NCT07189598 2026-04-30

ORION

Center Eugene Marquis

Phase NA Recruiting
390 enrolled
Genitourinary

Prostatic Neoplasms

NCT03371719 2026-01-14

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

NRG Oncology

Phase 2 Active not recruiting
324 enrolled
Genitourinary

Prostatic Neoplasms

NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡